Comparison of Caudal Block Combined With General Anesthesia and Penile Block and Intravenous Fentanyl in Pediatric Surgeries
Launched by MIRAY GÖZDE ÖZDEMIR · Mar 3, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief for boys aged 4 months to 12 years who are undergoing urogenital surgeries, which are common procedures in children. The researchers want to find out which method works better: a caudal block (a type of regional anesthesia that numbs the lower body) combined with general anesthesia, or a penile block along with intravenous fentanyl (a strong pain medication). By comparing these methods, the team hopes to learn more about how well they control pain after surgery, how quickly patients can walk and urinate afterward, and how they feel overall.
To participate in the study, boys must be between 4 months and 12 years old and scheduled for urogenital surgery. They also need to be generally healthy and able to agree to join the study. Unfortunately, boys with certain health issues, such as bleeding disorders or developmental delays, cannot participate. The study has not started recruiting participants yet, but once it does, those who join can expect to be monitored closely during their surgery and recovery to help the researchers gather important information about the effectiveness of the pain relief methods.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 4 months - 12 years old male patient
- • Acceptance of participation in the study
- • Patients Planned for Urogenital Surgery
- • ASA I-II Patients
- Exclusion Criteria:
- • \<4 months, \>12 years male patient
- • Female patient
- • Not accepted to be included in the study
- • ASA status III-IV
- • History of bleeding disorder
- • Spinal cord disease
- • Obstructive sleep apnea
- • Developmental delay
- • Behavioral disorder
- • Allergy to any drug in the protocol
About Miray Gözde özdemir
Miray Gözde Özdemir is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and robust methodologies. With a focus on ethical standards and regulatory compliance, the organization collaborates with healthcare professionals and research institutions to facilitate the development of new therapies across various therapeutic areas. Miray Gözde Özdemir emphasizes transparency and integrity in all aspects of clinical trials, ensuring that participant safety and data integrity remain paramount throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yenimahalle, Ankara, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported